
HealthEquity (HQY) Stock Forecast & Price Target
HealthEquity (HQY) Analyst Ratings
Bulls say
HealthEquity is a leader in the growing healthcare technology market and has established a strong presence through its mobile app and marketplace. In addition, the company's focus on sustainability and commitment to expansion opportunities provide a promising outlook for future growth. With a low valuation and strong potential for continued success, HealthEquity's stock presents a compelling investment opportunity for those looking to gain exposure to the healthcare technology sector.
Bears say
HealthEquity is poised for potential growth and operating margin expansions, with its transformation into a digital platform offering multiple sources of monetization and increased efficiencies. However, risky factors like falling interest rates and growing competition could hinder its growth and margin growth potential as well as uncertain post-pandemic recovery. Despite a strong account and HSA growth, near-term labor market conditions could also pose a threat to its growth. This outlook is supported by HealthEquity trading at a discount to its historical mean, with a 12.9x 2026 EBITDA estimate and a 19.6x 2026 P/E, indicating potential for a re-rate.
This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.
HealthEquity (HQY) Analyst Forecast & Price Prediction
Start investing in HealthEquity (HQY)
Order type
Buy in
Order amount
Est. shares
0 shares